Anti-PD-1 and CapOx for the First-line Treatment of dMMR Esophagogastric Cancer (AuspiCiOus)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(8 sites)

Netherlands

Academic Medical Center, Medical Oncology, Amsterdam

Amsterdam UMC, location VUmc, Amsterdam

Catharina ziekenhuis, Eindhoven

Medisch Centrum Leeuwarden, Leeuwarden

LUMC, Leiden

Radboud UMC, Nijmegen

Erasmus MC, Rotterdam

UMC Utrecht, Utrecht